158 related articles for article (PubMed ID: 9163650)
1. Disabling dyspnoea in patients with advanced disease: lack of effect of nebulized morphine.
Noseda A; Carpiaux JP; Markstein C; Meyvaert A; de Maertelaer V
Eur Respir J; 1997 May; 10(5):1079-83. PubMed ID: 9163650
[TBL] [Abstract][Full Text] [Related]
2. Lack of effect of high doses of inhaled morphine on exercise endurance in chronic obstructive pulmonary disease.
Jankelson D; Hosseini K; Mather LE; Seale JP; Young IH
Eur Respir J; 1997 Oct; 10(10):2270-4. PubMed ID: 9387952
[TBL] [Abstract][Full Text] [Related]
3. Effect of nebulized morphine in cancer patients with dyspnea: a pilot study.
Tanaka K; Shima Y; Kakinuma R; Kubota K; Ohe Y; Hojo F; Matsumoto T; Ohmatsu H; Goto K; Nagai K; Nishiwaki Y
Jpn J Clin Oncol; 1999 Dec; 29(12):600-3. PubMed ID: 10721941
[TBL] [Abstract][Full Text] [Related]
4. Dosimetrically administered nebulized morphine for breathlessness in very severe chronic obstructive pulmonary disease: a randomized, controlled trial.
Janowiak P; Krajnik M; Podolec Z; Bandurski T; Damps-Konstańska I; Sobański P; Currow DC; Jassem E
BMC Pulm Med; 2017 Dec; 17(1):186. PubMed ID: 29228935
[TBL] [Abstract][Full Text] [Related]
5. Nebulized opioids for the palliation of dyspnea in terminally ill patients.
Afolabi TM; Nahata MC; Pai V
Am J Health Syst Pharm; 2017 Jul; 74(14):1053-1061. PubMed ID: 28687551
[TBL] [Abstract][Full Text] [Related]
6. Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases.
Gamborg H; Riis J; Christrup L; Krantz T
J Opioid Manag; 2013; 9(4):269-74. PubMed ID: 24353020
[TBL] [Abstract][Full Text] [Related]
7. Nebulized morphine for relief of dyspnea due to chronic lung disease.
Brown SJ; Eichner SF; Jones JR
Ann Pharmacother; 2005 Jun; 39(6):1088-92. PubMed ID: 15840735
[TBL] [Abstract][Full Text] [Related]
8. Nebulized morphine for the relief of dyspnea.
Mabe SR; Connelly JF
Am J Health Syst Pharm; 1995 Jan; 52(2):146-8. PubMed ID: 12879541
[No Abstract] [Full Text] [Related]
9. Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study.
Bruera E; Sala R; Spruyt O; Palmer JL; Zhang T; Willey J
J Pain Symptom Manage; 2005 Jun; 29(6):613-8. PubMed ID: 15963870
[TBL] [Abstract][Full Text] [Related]
10. [Symptomatic treatment of dyspnoea in patients receiving palliative care: nasal delivery of oxygen compared with opioid administration].
Clemens KE; Klaschik E
Dtsch Med Wochenschr; 2007 Sep; 132(38):1939-43. PubMed ID: 17853348
[TBL] [Abstract][Full Text] [Related]
11. Effect of low dose nebulised morphine on exercise endurance in patients with chronic lung disease.
Young IH; Daviskas E; Keena VA
Thorax; 1989 May; 44(5):387-90. PubMed ID: 2669222
[TBL] [Abstract][Full Text] [Related]
12. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial.
Mazzocato C; Buclin T; Rapin CH
Ann Oncol; 1999 Dec; 10(12):1511-4. PubMed ID: 10643545
[TBL] [Abstract][Full Text] [Related]
13. Nebulized morphine as a treatment for dyspnea in a child with cystic fibrosis.
Cohen SP; Dawson TC
Pediatrics; 2002 Sep; 110(3):e38. PubMed ID: 12205288
[TBL] [Abstract][Full Text] [Related]
14. Nebulised morphine for severe interstitial lung disease.
Polosa R; Simidchiev A; Walters EH
Cochrane Database Syst Rev; 2002; 2002(3):CD002872. PubMed ID: 12137662
[TBL] [Abstract][Full Text] [Related]
15. A randomised study comparing the effectiveness of acupuncture or morphine versus the combination for the relief of dyspnoea in patients with advanced non-small cell lung cancer and mesothelioma.
Minchom A; Punwani R; Filshie J; Bhosle J; Nimako K; Myerson J; Gunapala R; Popat S; O'Brien ME
Eur J Cancer; 2016 Jul; 61():102-10. PubMed ID: 27156228
[TBL] [Abstract][Full Text] [Related]
16. Does nebulized morphine offer symptom relief to patients with disabling dyspnea during end-stage disease?
Eaton B; Hall J; MacDonald S
Can Fam Physician; 1999 Feb; 45():319-20. PubMed ID: 10065305
[No Abstract] [Full Text] [Related]
17. Acute respiratory depression as a complication of nebulised morphine.
Lang E; Jedeikin R
Can J Anaesth; 1998 Jan; 45(1):60-2. PubMed ID: 9466030
[TBL] [Abstract][Full Text] [Related]
18. Does oxygen help dyspnea in patients with cancer?
Booth S; Kelly MJ; Cox NP; Adams L; Guz A
Am J Respir Crit Care Med; 1996 May; 153(5):1515-8. PubMed ID: 8630595
[TBL] [Abstract][Full Text] [Related]
19. Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline.
Charles MA; Reymond L; Israel F
J Pain Symptom Manage; 2008 Jul; 36(1):29-38. PubMed ID: 18358689
[TBL] [Abstract][Full Text] [Related]
20. Low-dose nebulized morphine does not improve exercise in interstitial lung disease.
Harris-Eze AO; Sridhar G; Clemens RE; Zintel TA; Gallagher CG; Marciniuk DD
Am J Respir Crit Care Med; 1995 Dec; 152(6 Pt 1):1940-5. PubMed ID: 8520759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
